ALEXANDER BALAEZ: Open Payments
NPI 1972134286 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,102 in 30 payments from 9 companies in 2025. Trend: 2023 $1,132 · 2024 $1,586 · 2025 $1,102
Food & beverage: $1,102
| Company | Payments | Amount |
|---|---|---|
| Cleerly, Inc. | 10 | $580 |
| Boston Scientific Corporation | 3 | $184 |
| AstraZeneca Pharmaceuticals LP | 5 | $93 |
| PFIZER INC. | 4 | $91 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: Cleerly Ischemia, General - Ultrasound, VYNDAQEL, ELIQUIS, LEQVIO, CAMZYOS, WAINUA, KEVEYIS.
Industry payments across FL — which companies pay providers there.
